Federal contract award
W81K0024P0175
BLOOD CARDS AND REAGENTS FOR THE GOVERNMENT-OWNED ORTHO VISION ID-MTS WORKSTATION
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $48.3K |
| Current contract value | $72.5K |
| Potential contract value / ceiling | $120.9K |
| Start date | Oct 1, 2024 |
| Current end date | Sep 30, 2027 |
| Potential end date | Sep 30, 2029 |
| Latest award activity | May 1, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 1, 2026 | P00005 | $0 | BLOOD BANK REAGENTS |
| Dec 16, 2025 | P00004 | $24.2K | THE PURPOSE OF THIS NO COST MODIFICATION IS TO CHANGE THE CONTRACTOR NAME ON THE CONTRACT DUE TO THE EXECUTED NOVATION AGREEMENT BETWEEN ORTHO CLINICAL DIAGNOSTICS, INC, CAGE 03KD1 AND QUIDELORTHO SALES COMPANY, LLC, CAGE 12B04. |
| Jul 17, 2025 | P00003 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO CHANGE THE CONTRACTOR NAME ON THE CONTRACT DUE TO THE EXECUTED NOVATION AGREEMENT BETWEEN ORTHO CLINICAL DIAGNOSTICS, INC, CAGE 03KD1 AND QUIDELORTHO SALES COMPANY, LLC, CAGE 12B04. |
| Apr 30, 2025 | P00002 | $0 | ALBA Q CHECK Z498 |
| Oct 18, 2024 | P00001 | $24.2K | BLOOD CARDS AND REAGENTS FOR THE GOVERNMENT-OWNED ORTHO VISION ID-MTS WORKSTATION |
Estimated positioning window
Sep 30, 2028 – Mar 30, 2029
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2029-09-30 (1064 days from calculation)
- +15 points
- 80 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-05-01
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.